Edgewise 制药 EWTX
$45.04 +$6.17 (+15.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $45.28 +0.53%
开盘$39.71
昨收$38.87
当日区间$38.05 – $45.76
成交量3.72M
市值$4.93B
市盈率（TTM）5.4
股息率–
EWTX 相关新闻
匹配 Edgewise Therapeutics 或代码 EWTX 的头条新闻，按最新排序。
- Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Edgewise Therapeutics (EWTX) 正面
- RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $59
- Truist Financial Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating
- H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $57
- Wedbush Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53 正面
- Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Lexeo Therapeutics, Inc. (LXEO) and Edgewise Therapeutics (EWTX)
- H.C. Wainwright Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $57
- H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45
- Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55
- J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $60 正面
- J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $60
- Guggenheim Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $51 正面
- Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $55 正面
- Oppenheimer Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $51
- J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53 正面
暂无评论——快来第一个聊聊 EWTX。
登录后参与讨论。